|
|
|
|
|
|
NARFE June
As we come to an end to Alzheimer's & Brain Awareness Month — a global initiative to raise awareness, encourage action and create dialogue about Alzheimer's and other dementias — we are so thankful for the action NARFE and its members have taken to show their support.
We welcome you to keep the momentum going this summer! There's still time to join the NARFE Walk to End Alzheimer's® team and go purple — the color of Alzheimer's. We are so grateful to have partners who share our vision of a world without Alzheimer's and all other dementia.
|
|
|
Clinical trials continue during COVID-19
Many clinical trials have been impacted by COVID-19 due to self-isolation, physical distancing, travel limitations and site closures. But virtual clinical trials and observational studies are still underway and continue to collect important data related to Alzheimer's and the brain. Learn more.
|
|
|
|
|
COVID-19 creates crisis for individuals in long-term care facilities
Nearly half of all long-term care facility residents are living with Alzheimer's or dementia, increasing their susceptibility to COVID-19. Alzheimer's Association President and CEO Harry Johns spoke with ABC News about the impact COVID-19 is having on individuals in these settings and what the Association is calling for to improve conditions. Learn more.
|
|
|
|
|
Late stage of Alzheimer's can last from several weeks to several years
As Alzheimer's advances, intensive, around-the-clock care is usually required, and the needs of the person living with the disease will change. During the late stage, a caregiver's role will focus on preserving quality of life and dignity. Learn more.
|
|
|
|
|
View Past Issues
|
|
|
|
|
NARFE 2020 Goal $14 Million
|
|
|
|
24/7 Helpline: 1-800-272-3900
|
|
